| Today, Mon, Nov 9, 2009 | | • | UPDATE - Qiagen beats estimates, tweaks outlook on test sales
at Reuters (Mon 4:07pm)
| | • | Morningstar Strategist Says Healthcare Bill Will Be Law By End Of Year: Is Your Portfolio Ready?
Wall Street Transcript (Mon 1:47pm)
| | • | U.S. Healthcare Legislation Investment Impact
at Seeking Alpha (Mon 5:07am)
| | • | [video] Practicing Balance With P&G: China Watch
at TheStreet.com (Mon 5:00am)
| | Sun, Nov 8, 2009 | | • | Make Millions From Thousands
at Motley Fool (Sun 9:00am)
| | Sat, Nov 7, 2009 | | • | Your Best Chance to Profit in 2009
at Motley Fool (Sat, Nov 7)
| | Fri, Nov 6, 2009 | | • | AMGEN INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | • | Biotech Stock Mailbag: Poniard Predictions
at TheStreet.com (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Mixed Results For Amgens Latest Vectibix Trial
at Fox Business (Thu, Nov 5)
| | • | This Top Stock Is a Winner
at Motley Fool (Thu, Nov 5)
| | • | Placing Bets On Human Genome's Benlysta
Indie Research (Thu, Nov 5)
| | • | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
| | • | Your Biggest Blunder's Not the One You Think
at Motley Fool (Thu, Nov 5)
| | • | Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
PR Newswire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Why Cuomo Slapped Intel
at Forbes.com (Wed, Nov 4)
| | • | Call for Applications: The Amgen Award for Science Teaching Excellence
PR Newswire (Wed, Nov 4)
| | • | Bargain Stocks Are Still Out There
at Motley Fool (Wed, Nov 4)
| | • | Intel in the Anti-Trust Crosshairs, but Why?
at CNBC (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | These Cash Hoarders Will Make You Rich
at Motley Fool (Tue, Nov 3)
| | • | Obamacare Positive To Net Neutral For Pharmaceutical Industry According To Analysis By Morningstar Expert
Wall Street Transcript (Tue, Nov 3)
|
Add AMGN News to My Yahoo!:
 
| |
|
2.03% Nasdaq 
Headlines
